Related Experiment Video
Updated: Oct 12, 2025

09:34
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
9.1K
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental
Eride Quarta1,2, Fabio Sonvico1, Ruggero Bettini1
1Food and Drug Department, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy.
Pharmaceutics
|November 27, 2021
Summary
We developed respirable dry powders containing Calcium Phosphate nanoparticles (CaPs) for lung-to-heart drug delivery. A 1:4 CaPs/mannitol ratio yielded hollow microparticles with optimal aerodynamic properties for myocardial targeting.
Area of Science:
- Nanomedicine
- Pharmaceutical Sciences
- Biomaterials Engineering
Background:
- Calcium Phosphate nanoparticles (CaPs) show potential for lung-to-heart drug delivery to myocardial cells.
- Developing effective inhalation systems is crucial for targeted nanomedicine delivery.
Purpose of the Study:
- To develop a novel, highly respirable dry powder formulation embedding crystalline CaPs.
- To optimize the formulation using a Quality by Design approach for inhalation applications.
Main Methods:
- Spray drying technique was employed to create dry microparticles using mannitol as a matrix excipient.
- A Quality by Design approach investigated the impact of feed composition and spray rate on powder attributes.
- In vitro aerodynamic performance, inner structure, and morphology of microparticles were evaluated.
Main Results:
- The 1:4 ratio of CaPs to mannitol resulted in hollow microparticles with superior aerodynamic performance.
- Spray drying successfully produced respirable dry powders.
- Released CaPs maintained their original size after microparticle dissolution.
Conclusions:
- Hollow microparticles formulated with a 1:4 CaPs/mannitol ratio are promising for inhalation drug delivery.
- The developed system facilitates targeted lung-to-heart delivery of CaPs to myocardial cells.
- This approach offers a viable strategy for novel nanomedicine delivery systems.

